BUY SIDE BRO

NAT. BANK FPO [NAB] NAB.AX

Latest Deep Dive · Written · AI research note

Bro's Verdict
Deep Dive

Rating

HOLD

Confidence

60%

Target Price

A$37.00

Upside

-5.7%

Horizon

medium

NAB trades at 16.9x NTM P/E, the cheapest major bank on a forward basis, but sits +83% above its own 2-year average forward P/E and 2.0x book versus a 1.6x average, pricing in a recovery that consensus numbers do not support. With forward EPS growth of -7.9% and EBIT growth of -3.4%, the earnings trajectory is negative, though the 12.2% six-month share price fall and stabilising EPS revisions suggest much of the bad news may be priced in. The $37 target implies roughly 6% downside plus a 4.1% dividend yield for a near-flat total return, so risk-reward is balanced.

Executive Summary

•NAB trades at 16.9x NTM P/E on $2.32 forward EPS, the cheapest of the four major banks on a forward basis, but sits +83% above its own 2 year average forward P/E of 8.8x, implying the market has already re rated the stock well ahead of fundamentals.
•Consensus NTM EPS has been essentially flat ($2.43 vs $2.42 one month ago, +0.5%) while the share price fell 12.2% over six months, a divergence that suggests earnings downgrades are stabilising even as sentiment stays weak.
•The core earnings engine is under pressure: consensus EPS growth of -7.9% and EBIT growth of -3.4% point to net interest margin compression and rising impairment charges outweighing volume growth.
•Capital return and cost discipline are the swing factors; a strong CET1 position supports buyback capacity, but technology simplification spend and wage inflation are capping positive jaws.

Financial Snapshot

•Market Cap: ~$122b at $39.25 (Yahoo's $226.15b appears erroneous; ASX share count of 3.12b and EV of $128.8b imply ~$122b to $129b)
•Revenue (TTM): $20.86b
•Net Margin: 29.3%
•Operating Margin: 50.0%
•Forward EPS (NTM): $2.32 (ASX consensus) vs $2.43 (revision trend series)
•Forward P/E: 16.9x NTM
•EPS Growth (forward): -7.9%
•Dividend Yield: 4.12% (ASX series; a secondary source cites 8.8%, treat the higher figure with caution)
•Consensus DPS: $0.04 (appears mis scaled, Not disclosed on a reliable basis)
•Net Debt / EV: 0.01x (structurally low given deposit funded balance sheet)
•ROE: Not disclosed (0.1% in the data set is clearly erroneous)
•52 week range: $35.48 to $49.45

Forward Outlook

•Revenue guidance: consensus revenue of ~$22b implies low single digit growth, consistent with a mature, volume led banking model.
•EPS estimates: consensus NTM EPS of $2.32 implies a -7.9% decline year over year, with the revision series ($2.43) modestly above the ASX figure, so the true forward run rate sits between the two.
•Margin trajectory: NIM expected to remain under pressure from deposit repricing and competitive mortgage pricing; management commentary flags further compression before stabilisation. Specific NIM guidance: Not disclosed.
•Consensus EBIT of ~$11.1b and EBIT growth of -3.4% signal flat to modestly declining operating income as margin pressure offsets lending growth.
•EBITDA growth of +5.8% is the one positive forward signal, though this is a low quality metric for a bank and should be discounted.
•Target price consensus of $38.40 sits marginally below the current $39.25, implying limited near term upside on sell side numbers.

Valuation Analysis

•NTM P/E: 16.9x on $2.32 forward EPS
•TTM P/E: 17.8x (ASX Bloomberg series)
•NTM EV/EBIT: 11.8x (ASX series)
•BF EV/EBIT: 20.9x vs 2 year average 14.8x (+41% vs avg, +0.7 SD); implied price at average $17.63
•BF P/E: 16.1x vs 2 year average 8.8x (+83% vs avg, +1.8 SD), the most stretched metric in the set; implied price at average $21.46
•LF P/BV: 2.0x vs 2 year average 1.6x (+25% vs avg, +1.2 SD); implied price at average book multiple $31.43
•BF EV/Rev: 9.9x vs 2 year average 5.8x (+71% vs avg, +1.0 SD); implied price at average $8.52 (distorted by revenue definition)
•BF EV/EBITDA: 19.8x vs 2 year average 21.5x (-8% vs avg, -0.1 SD); implied price at average $45.76, the only metric pointing higher and the least reliable for a bank
•Fair value range: $34 to $38 based on peer relative and historical mean reversion
•CBA: ~23.7x TTM P/E, $258.3b market cap, premium franchise multiple
•WBC: ~17.3x TTM P/E, $120.1b market cap, closest valuation comparable
•ANZ: ~19.5x TTM P/E, $115.6b market cap, institutional and Asia tilt
•MQG: ~25.9x TTM P/E, $96.0b market cap, capital markets earnings mix
•NAB screens cheapest of the majors on forward P/E but the discount reflects lower expected EPS growth and margin headwinds

Key Risks & Catalysts

Risks

•Net interest margin compression from deposit repricing and aggressive mortgage discounting could drive EPS below the -7.9% consensus.
•Australian mortgage book growth is slowing amid competitive pricing pressure, with volume gains unlikely to offset margin dilution.
•Impairment charges and arrears in SME and consumer lending are trending higher, with provisions raised against economic shock and geopolitical risk.
•Cost inflation and technology simplification spend may prevent positive jaws, keeping the cost to income ratio elevated.
•Valuation risk: forward P/E at +1.8 SD above its 2 year average leaves little room for disappointment.
•Dividend sustainability risk if cash earnings decline further, given the payout ratio is already high.

Catalysts

•CET1 position and buyback capacity under APS 112/113 reforms could support capital return and the share price.
•Stabilisation in NTM EPS revisions (+0.5% over one month) may mark the trough in earnings downgrades.
•Cost discipline program delivering technology simplification savings could restore positive operating leverage.
•Any turn in the rate cycle easing deposit competition would relieve NIM pressure.
•Business and private banking lending growth remains a relative bright spot versus retail.
•New Zealand and corporate and institutional segments provide geographic and earnings diversification.

Investment Thesis

NAB is a high quality, deposit funded major bank trading at 16.9x NTM P/E, which looks reasonable against peers but is expensive against its own history. The +83% premium to its 2 year average forward P/E and 2.0x price to book versus a 1.6x average leave the stock priced for a recovery that consensus numbers do not yet support. With forward EPS growth of -7.9% and EBIT growth of -3.4%, the earnings trajectory is negative, driven by NIM compression from deposit and mortgage repricing, rising SME and consumer impairments, and cost inflation that technology simplification spend has yet to offset.

The bull case rests on capital and cost. A strong CET1 position under APS 112/113 supports buyback capacity and dividend resilience, and the modest +0.5% uptick in NTM EPS revisions over the past month hints that downgrades may be bottoming. If cost discipline restores positive jaws and deposit competition eases, the -7.9% EPS decline could prove conservative. The 12.2% six month share price fall has already de rated the stock, so much of the bad news may be priced in.

On balance NAB is a Hold with a 12 month price target of $37, implying roughly 6% downside from $39.25 plus the 4.1% dividend yield for a total return near flat. The risk reward is balanced: the cheapest major bank multiple is offset by the weakest forward EPS growth and the most stretched historical valuation. The stock becomes more interesting below $35, near the 52 week low, where the forward P/E compresses toward 15x and the historical premium narrows materially.

Written by Buy Side Bro's AI analyst from financials, consensus, filings and recent news. General information only, not financial advice.

Run your own analysis free

Buy Side Bro writes a note like this on any US, ASX or global stock in a few minutes: the thesis, valuation, catalysts, risks and a Buy, Hold or Sell call with a 12-month target. It comes with the daily market wrap, live markets, earnings and charts. Sign in and you get 7 days of full access free, no card needed.

iPhone app coming soon. The same account and subscription carry over.

See the latest research on other stocks